News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
INOVAIT awards two leading companies and one academic partner for transforming Canada’s healthcare ecosystem
TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to recognize INOVAIT members (Industry and Academic) who are developing breakthrough innovations in healthcare and spearheading economic development for Canada. "The INOVAIT awards grew out of our desire to recognize and spotlight members and institutions doing exceptional things to impact medtech innovation in Canada," said Raphael Ronen, co-executive director of INOVAIT. "Together, the recipients of the 2024 INOVAIT awards showcase Canada's…
2024 Discovery Forum Recap
Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.
Network News
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
INOVAIT’s Pilot Fund now accepting applications for image-guided therapy projects
October 18, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT), is now accepting...
Work in Canada’s IGT sector: IGT companies hiring right now
INOVAIT member companies are looking for talent that could help transform the delivery of healthcare. Could it be you?...
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media